Catherine Tomlinson takes an in-depth look at how Afrigen managed to reach this point and what further challenges have to be overcome before mRNA vaccines can be produced at scale in South Africa.
Cape Town-based biotechnology company Afrigen Biologics has successfully produced a lab-scale batch of a mRNA vaccine against Covid-19 that is similar to that made by pharmaceutical company Moderna. What happens now?